Skip to menu Skip to content Skip to footer

Venom-derived blood-brain-barrier shuttles (2023-2026)

Abstract

The project investigates how venom compounds can reach targets in the brain and aims to use this knowledge to develop non-toxic and non-invasive brain delivery systems. This research will lead to several benefits: (i) knowledge gains on naturally evolved strategies to get macromolecules across the blood-brain-barrier; (ii) technological advancements in brain delivery strategies and probe development to accelerate fundamental research; (iii) economic benefits, as breakthroughs in brain delivery technologies can lead to multi-million-dollar returns; (iv) enhancement of Australia's research capacity due to the project's multidisciplinary nature, the outstanding research environment, the knowledge/skill transfer from Europe to Australia, and the world-class training of the next generation of scientists; (v) promotion of Australias scientific excellence and recognition in the areas of chemical biology and natural product discovery research, via both academic and non-academic channels, and (vi) new national and international collaborations to strengthen Australias competitiveness on an international level.

Experts

Associate Professor Markus Muttenthaler

Affiliate of Centre for Chemistry and Drug Discovery
Centre for Chemistry and Drug Discovery
Institute for Molecular Bioscience
ARC Future Fellow & Group Leader
Institute for Molecular Bioscience
Markus Muttenthaler
Markus Muttenthaler